NO993412D0 - Nye IFN-reseptor -1-bindende proteiner, DNA som koder for dem og metoder for modulering av cellulaer respons for interferoner - Google Patents

Nye IFN-reseptor -1-bindende proteiner, DNA som koder for dem og metoder for modulering av cellulaer respons for interferoner

Info

Publication number
NO993412D0
NO993412D0 NO993412A NO993412A NO993412D0 NO 993412 D0 NO993412 D0 NO 993412D0 NO 993412 A NO993412 A NO 993412A NO 993412 A NO993412 A NO 993412A NO 993412 D0 NO993412 D0 NO 993412D0
Authority
NO
Norway
Prior art keywords
cellular response
dna encoding
interferons
methods
binding proteins
Prior art date
Application number
NO993412A
Other languages
English (en)
Other versions
NO326104B1 (no
NO993412L (no
Inventor
Michel Revel
Carolina Abramovitch
Judith E Chebath
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO993412D0 publication Critical patent/NO993412D0/no
Publication of NO993412L publication Critical patent/NO993412L/no
Publication of NO326104B1 publication Critical patent/NO326104B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19993412A 1997-01-15 1999-07-09 Nye IFN-reseptor -1-bindende proteiner, DNA som koder for dem og metoder for modulering av cellulaer respons for interferoner NO326104B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3563697P 1997-01-15 1997-01-15
PCT/US1998/000671 WO1998031796A1 (en) 1997-01-15 1998-01-15 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons

Publications (3)

Publication Number Publication Date
NO993412D0 true NO993412D0 (no) 1999-07-09
NO993412L NO993412L (no) 1999-07-09
NO326104B1 NO326104B1 (no) 2008-09-22

Family

ID=21883894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993412A NO326104B1 (no) 1997-01-15 1999-07-09 Nye IFN-reseptor -1-bindende proteiner, DNA som koder for dem og metoder for modulering av cellulaer respons for interferoner

Country Status (20)

Country Link
US (1) US7264945B2 (no)
EP (1) EP1019500B1 (no)
JP (1) JP4614473B2 (no)
KR (2) KR100591988B1 (no)
CN (1) CN1212398C (no)
AT (1) ATE342972T1 (no)
AU (1) AU731206C (no)
BG (1) BG64829B1 (no)
BR (1) BR9806755A (no)
CA (1) CA2276111A1 (no)
CZ (1) CZ299096B6 (no)
DE (1) DE69836226T2 (no)
DK (1) DK1019500T3 (no)
EA (1) EA003250B1 (no)
EE (1) EE04819B1 (no)
ES (1) ES2275297T3 (no)
IL (2) IL130960A0 (no)
NO (1) NO326104B1 (no)
UA (1) UA75560C2 (no)
WO (1) WO1998031796A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119129A1 (en) * 1997-01-15 2002-08-29 Yeda Research And Development Co. Ltd. Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
WO2003055506A1 (fr) * 2001-12-27 2003-07-10 Takeda Chemical Industries, Ltd. Medicaments pour la prevention et le traitement du cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4220759A1 (de) * 1992-06-24 1994-01-05 Inst Genbiologische Forschung DNA-Sequenzen für Oligosaccharid-Transporter, Plasmide, Bakterien und Pflanzen enthaltend einen Transporter sowie Verfahren zur Herstellung und Transformation von Hefestämmen zur Identifikation des Transporteers
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
US6242587B1 (en) * 1996-10-02 2001-06-05 The University Of North Carolina At Chapel Hill DNA molecules encoding a calcium-integrin binding protein

Also Published As

Publication number Publication date
EE04819B1 (et) 2007-04-16
AU731206C (en) 2002-05-16
WO1998031796A8 (en) 1999-05-20
EE9900272A (et) 2000-02-15
AU5824098A (en) 1998-08-07
EA199900663A1 (ru) 2000-02-28
DE69836226T2 (de) 2007-02-01
CN1243544A (zh) 2000-02-02
CN1212398C (zh) 2005-07-27
US7264945B2 (en) 2007-09-04
KR100799828B1 (ko) 2008-01-31
EP1019500B1 (en) 2006-10-18
IL130960A (en) 2008-03-20
WO1998031796A1 (en) 1998-07-23
BR9806755A (pt) 2000-03-14
NO326104B1 (no) 2008-09-22
EA003250B1 (ru) 2003-02-27
ES2275297T3 (es) 2007-06-01
JP4614473B2 (ja) 2011-01-19
CA2276111A1 (en) 1998-07-23
DK1019500T3 (da) 2007-02-19
BG64829B1 (bg) 2006-05-31
KR20050046779A (ko) 2005-05-18
ATE342972T1 (de) 2006-11-15
BG103627A (en) 2000-04-28
CZ247199A3 (cs) 2000-01-12
JP2001508306A (ja) 2001-06-26
AU731206B2 (en) 2001-03-29
EP1019500A4 (en) 2004-04-07
NO993412L (no) 1999-07-09
KR100591988B1 (ko) 2006-06-21
IL130960A0 (en) 2001-01-28
CZ299096B6 (cs) 2008-04-23
KR20000070181A (ko) 2000-11-25
UA75560C2 (en) 2006-05-15
DE69836226D1 (de) 2006-11-30
EP1019500A2 (en) 2000-07-19
US20030176678A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
NZ502392A (en) Interleukin-18 binding proteins (IL-18BP) their preparation and use in pharmaceuticals
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
NO962346L (no) Humaniserte antistoffer og anvendelser derav
DK0712931T4 (da) Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma
DK0724588T3 (da) Lægemiddelbindende protein
HUP9902429A2 (hu) TNF-receptor-asszociált faktor (TRAF) modulátorok előállítása és alkalmazása
TR200000654T2 (tr) KAY-Yeni bir bağışıklık sistemi proteini.
DE69839340D1 (de) Mutanten DES VASKULÄREN, ENDOTHELZELLEN-SPEZIFISCHEN WACHSTUMSFAKTORS C (VEGF-C) UND DEREN VERWENDUNGEN
ES8506087A1 (es) Procedimiento para preparar proteina de uroquinasa humana bioactiva
KR900011900A (ko) 이.콜라이내에서 펩타이드를 분비시키기 위한 시그날 펩타이드 및 이를 암호화하는 유전자
ATE327328T1 (de) Adipozyten-spezifische protein homologe
DK0954333T3 (da) Oplöselige lymfotoksin-beta-receptorer, anti-lymfotoksinreceptor-antistoffer og anti-lymfotoksin-ligandantistoffer som terapeutiske midler til behandling af immunologiske sygdomme
EP0851030A4 (en) PROTEIN, SPECIFIC TO HUMAN Th2 CELLS, FOR ENCODING GENE AND CORRESPONDING TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY
NO904024L (no) Heparin-bindende proteiner, dna som koder for dem, fremgangsmaater for fremstilling derav og terapeutisk preparater inneholdende dem.
FR2706484B1 (fr) Polypeptide mutant de la protéine kinase C, séquences d'acides nucléiques codant pour ledit polypeptide et leurs utilisations.
ATE443761T1 (de) Rtd receptor
NO993412D0 (no) Nye IFN-reseptor -1-bindende proteiner, DNA som koder for dem og metoder for modulering av cellulaer respons for interferoner
ATE452650T1 (de) Transferrin-fusionsproteinbibliotheken
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
DK312787D0 (da) Polypeptider, fremgangsmaade til deres fremstilling, dna som koder for polypeptiderne, vektorer indeholdende saadanne gensekvenser og laegemidler indeholdende polypeptiderne
WO2000053733A3 (en) Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
DK8089A (da) Monoclonale antistoffer, deres fremstilling og anvendelse.
HUP9801062A2 (hu) Új PKA-kötődő fehérjék, és ezek alkalmazása
DK31589A (da) Assay for begyndende diabetes, monoklonale antistoffer til anvendelse herved og saet til anvendelse hertil.
FR2699922B1 (fr) Polypeptides à activité de récepteur sérotoninergique, médicaments les comprenant, séquences codant pour eux, sondes vecteurs et hôtes les exprimant, et application au criblage des médicaments.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees